Risk factors for intrahepatic cholangiocarcinoma: Association between metformin use and reduced cancer risk
Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, W. Ray Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau, Lewis R. Roberts – 11 October 2012 – The associations between diabetes, smoking, obesity, and intrahepatic cholangiocarcinoma (ICC) risk remain inconclusive. Metformin is purportedly associated with a reduced risk for various cancers. This case‐control study evaluated risk factors for ICC and explored the effects of metformin on ICC risk in a clinic/hospital‐based cohort.